A New VISTA on combination therapy for negative checkpoint regulator blockade

Negative checkpoint regulators function to restrain T cell responses to maintain tolerance and limit immunopathology. However, in the setting of malignancy, these pathways work in concert to promote immune-mediate escape leading to the development of a clinically overt cancer. In the recent years, c...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Journal for immunotherapy of cancer Ročník 4; číslo 1; s. 86
Hlavní autoři:	Deng, Jie, Le Mercier, Isabelle, Kuta, Anna, Noelle, Randolph J.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	London BMJ Publishing Group Ltd 20.12.2016 BioMed Central BioMed Central Ltd BMJ Publishing Group LTD BMJ Publishing Group
Témata:	Antigens Apoptosis Cancer Cancer therapies Combination drug therapy Combination immunotherapy Drugs Enzyme inhibitors FDA approval Immune response Immunology Immunotherapy Ligands Lung cancer Lymphocytes Medicine Medicine & Public Health Melanoma Methods Monoclonal antibodies Negative checkpoint regulators Observations Oncology Patient outcomes Phosphatase Review Reviews T cell receptors Tumors VISTA Negative checkpoint regulators Combination immunotherapy VISTA
ISSN:	2051-1426, 2051-1426
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!